Carbohydrate recognition underpinning diagnosis and therapy

Iceni Diagnostics is focused on the development of carbohydrate-based therapeutics and point-of-care diagnostics for infectious diseases.

Capitalising on its expertise in carbohydrate and analytical chemistry, Iceni Diagnostics provides bespoke solutions in glycoscience R&D, nanoparticle technology and bioconjugation chemistry. Iceni Diagnostics is developing a portfolio of in-house programmes, as well as engaging in collaborative and contract R&D activities, through engagement with the UK biotech sector and Government Research Organisations. Current projects include the development of novel point-of-care diagnostics and new chemical and enzymatic approaches to the production of carbohydrate-containing biopharmaceuticals.

Interested in finding out more?

Contact us